Total Payments
$8,835
2024 Payments
$1,719
Companies
67
Transactions
481
Medicare Patients
747
Medicare Billing
$174,079
Payment Breakdown by Category
Food & Beverage$8,695 (98.4%)
Other$134.68 (1.5%)
Education$4.99 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,695 | 474 | 98.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $134.68 | 6 | 1.5% |
| Education | $4.99 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,637 | 97 | $0 (2024) |
| Biogen, Inc. | $575.25 | 36 | $0 (2022) |
| UCB, Inc. | $521.54 | 21 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $462.00 | 28 | $0 (2024) |
| Genentech USA, Inc. | $387.91 | 19 | $0 (2023) |
| PFIZER INC. | $376.40 | 26 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $359.11 | 14 | $0 (2024) |
| Allergan, Inc. | $330.14 | 23 | $0 (2020) |
| Eisai Inc. | $306.89 | 13 | $0 (2024) |
| Lilly USA, LLC | $262.22 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,719 | 81 | ABBVIE INC. ($296.15) |
| 2023 | $1,231 | 58 | AbbVie Inc. ($323.20) |
| 2022 | $1,281 | 74 | ABBVIE INC. ($440.67) |
| 2021 | $496.36 | 29 | AbbVie Inc. ($135.78) |
| 2020 | $661.76 | 40 | UCB, Inc. ($90.44) |
| 2019 | $1,050 | 57 | Novartis Pharmaceuticals Corporation ($205.60) |
| 2018 | $1,262 | 72 | Biogen, Inc. ($295.61) |
| 2017 | $1,133 | 70 | AbbVie, Inc. ($243.67) |
All Payment Transactions
481 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $29.66 | General |
| Category: Neurology | ||||||
| 12/17/2024 | Kedrion Biopharma, Inc. | Albuked (Biological), KOATE, GAMMAKED | Food and Beverage | Cash or cash equivalent | $16.59 | General |
| Category: Critical Care | ||||||
| 12/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $12.64 | General |
| Category: PAIN | ||||||
| 12/10/2024 | PFIZER INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $34.77 | General |
| Category: Neurology | ||||||
| 12/04/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $99.53 | General |
| Category: Neuroscience | ||||||
| 12/04/2024 | ACADIA Pharmaceuticals Inc | DAYBUE (Drug) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: RETT SYNDROME | ||||||
| 12/03/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $11.39 | General |
| Category: PAIN | ||||||
| 11/26/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $10.66 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $12.05 | General |
| Category: PAIN | ||||||
| 11/20/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $4.57 | General |
| Category: Neurology | ||||||
| 11/08/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/05/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $23.63 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 10/31/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $34.64 | General |
| Category: Neurology | ||||||
| 10/25/2024 | Lilly USA, LLC | EMGALITY (Drug), KISUNLA | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: Neuroscience | ||||||
| 10/21/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $27.20 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 10/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: PAIN | ||||||
| 10/08/2024 | GE HEALTHCARE | — | Food and Beverage | In-kind items and services | $14.24 | General |
| 10/03/2024 | Ipsen Biopharmaceuticals, Inc | Dysport (Drug) | Food and Beverage | In-kind items and services | $26.63 | General |
| Category: Neurology | ||||||
| 10/01/2024 | PFIZER INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: IMMUNOLOGY | ||||||
| 09/26/2024 | ABBVIE INC. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: NEUROSCIENCE | ||||||
| 09/25/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $34.78 | General |
| Category: Neurology | ||||||
| 09/23/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/19/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: PAIN | ||||||
| 09/18/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 117 | 4,430 | $81,281 | $35,557 |
| 2022 | 6 | 162 | 4,509 | $98,553 | $37,131 |
| 2021 | 9 | 223 | 6,446 | $159,464 | $53,907 |
| 2020 | 9 | 245 | 5,055 | $188,444 | $47,485 |
Total Patients
747
Total Services
20,440
Medicare Billing
$174,079
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 15 | 4,264 | $30,701 | $20,868 | 68.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 65 | 120 | $25,800 | $10,807 | 41.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 26 | 35 | $6,125 | $2,136 | 34.9% |
| 70553 | Mri scan of brain before and after contrast | Office | 2023 | 11 | 11 | $18,655 | $1,745 | 9.4% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 15 | 4,090 | $29,448 | $18,292 | 62.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 62 | 97 | $20,855 | $9,300 | 44.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 48 | 60 | $10,500 | $3,630 | 34.6% |
| 97112 | Therapy procedure to re-educate brain-to-nerve-to-muscle function, each 15 minutes | Office | 2022 | 12 | 99 | $14,700 | $2,470 | 16.8% |
| 97110 | Therapy procedure using exercise to develop strength, endurance, range of motion, and flexibility, each 15 minutes | Office | 2022 | 13 | 113 | $16,800 | $2,097 | 12.5% |
| 97530 | Therapy procedure using functional activities | Office | 2022 | 12 | 50 | $6,250 | $1,342 | 21.5% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2021 | 19 | 5,357 | $38,570 | $24,832 | 64.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 61 | 89 | $19,135 | $8,452 | 44.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 71 | 96 | $16,800 | $6,283 | 37.4% |
| 97110 | Therapeutic exercise to develop strength, endurance, range of motion, and flexibility, each 15 minutes | Office | 2021 | 13 | 206 | $30,900 | $3,997 | 12.9% |
| 97112 | Therapeutic procedure to re-educate brain-to-nerve-to-muscle function, each 15 minutes | Office | 2021 | 13 | 158 | $23,700 | $3,858 | 16.3% |
| 97140 | Manual (physical) therapy techniques to 1 or more regions, each 15 minutes | Office | 2021 | 12 | 200 | $15,000 | $3,490 | 23.3% |
| 97530 | Therapeutic activities to improve function, with one-on-one contact between patient and provider, each 15 minutes | Office | 2021 | 11 | 83 | $10,375 | $2,408 | 23.2% |
| 97150 | Therapeutic procedures in a group setting | Office | 2021 | 12 | 50 | $2,500 | $559.68 | 22.4% |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | Office | 2021 | 11 | 207 | $2,484 | $26.80 | 1.1% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2020 | 15 | 3,995 | $28,764 | $18,852 | 65.5% |
| 97110 | Therapeutic exercise to develop strength, endurance, range of motion, and flexibility, each 15 minutes | Office | 2020 | 16 | 323 | $48,450 | $6,425 | 13.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 93 | 133 | $23,275 | $6,335 | 27.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 46 | 78 | $16,770 | $5,668 | 33.8% |
| 97530 | Therapeutic activities to improve function, with one-on-one contact between patient and provider, each 15 minutes | Office | 2020 | 17 | 144 | $17,623 | $3,925 | 22.3% |
| 97112 | Therapeutic procedure to re-educate brain-to-nerve-to-muscle function, each 15 minutes | Office | 2020 | 14 | 149 | $22,350 | $3,433 | 15.4% |
About Dr. Anna Tseng, MD
Dr. Anna Tseng, MD is a Neurology healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1053417964.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anna Tseng, MD has received a total of $8,835 in payments from pharmaceutical and medical device companies, with $1,719 received in 2024. These payments were reported across 481 transactions from 67 companies. The most common payment nature is "Food and Beverage" ($8,695).
As a Medicare-enrolled provider, Tseng has provided services to 747 Medicare beneficiaries, totaling 20,440 services with total Medicare billing of $174,079. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Dallas, TX
- Active Since 09/16/2006
- Last Updated 01/16/2026
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1053417964
Products in Payments
- QULIPTA (Drug) $513.17
- BOTOX (Biological) $395.24
- Briviact (Drug) $360.20
- NURTEC ODT (Drug) $325.22
- Zinbryta (Biological) $265.63
- OCREVUS (Biological) $261.24
- UBRELVY (Drug) $230.16
- TYSABRI (Biological) $214.86
- Leqembi (Drug) $213.08
- KESIMPTA (Drug) $207.95
- SOLIRIS (Drug) $189.31
- OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug) $170.04
- Xeomin (Biological) $161.77
- Duopa (Drug) $158.27
- BRIUMVI (Drug) $150.32
- TECFIDERA (Drug) $148.93
- KISUNLA (Drug) $145.99
- GILENYA (Drug) $139.52
- DUOPA (Drug) $137.85
- Enspryng (Biological) $126.67
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Dallas
Nirav Pavasia, M.d, M.D
Neurology — Payments: $1.3M
Neurology $1.3M
Benjamin Greenberg, Md, MD
Neurology — Payments: $691,893
Neurology $691,893
Steven Herzog, M.d, M.D
Neurology — Payments: $519,302
Neurology $519,302
Waleed El-Feky, M.d, M.D
Neurology — Payments: $469,716
Neurology $469,716
Mark Alberts, Md, MD
Neurology — Payments: $417,917
Neurology $417,917
Adnan Subei, D.o, D.O
Neurology — Payments: $274,043
Neurology $274,043